S10 Ep16: Mims Expands on the Evaluation of Emavusertib in the TakeAim Leukemia Trial of AML and MDS

OncLive® On Air - Un pódcast de OncLive® On Air

prueba podimo gratis durante 60 días!

Miles de audiolibros y podcasts exclusivos, haz clic aquí para probar

Dr Mims discusses the utility of emavusertib in acute myeloid leukemia and myelodysplastic syndrome and the rationale for the TakeAim Leukemia trial.